America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Read these first
- How Virtual Reality Is Transforming HealthcareHealth practitioners are exploring exciting ways that VR can assist patients and health providers to achieve better treatments and outcomes.
- Growing By Investing In Health Across The AmericasBusiness and government leaders discuss the importance of investing in healthcare and citizens’ well-being for a better future for the nations of the Americas.
- Experts Weigh In on the Future of Healthcare and the WorkforceThe U.S. Chamber AI Commission hosted a field hearing in Cleveland, OH, examining how AI is impacting the healthcare industry.
The new study by the U.S. Chamber and Avalere finds employers that offer higher quality coverage and higher wages can expect to see a higher return on their wellness and health insurance programs.
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Chairman and CEO of Pfizer Dr. Albert Bourla discusses how innovations made in the pursuit of Pfizer’s COVID-19 vaccine have led to new advancements in health care.
- InternationalInSTEP: The Ongoing Russia-Ukraine Conflict and Geopolitical ImplicationsMonday, October 0304:00 PM EDT - 05:00 PM EDT
- Health CareHealth ForwardTuesday, October 0401:00 PM EDT - 03:00 PM EDT
- FinanceProlific Regulation: Examining SEC Rulemaking Under the Biden AdministrationThursday, October 0611:00 AM EDT - 11:30 AM EDT
- Jul 29, 2021U.S. Chamber Letter on Antitrust Legislation to the Senate Judiciary Committee
This Hill letter was sent to the Members of the Senate Committee on the Judiciary, on several bills scheduled to be considered during a July 29 hearing.
- Jul 27, 2021Employer-Sponsored Insurance Delivers $1.5 Trillion in Value for Employees, U.S. Economy
Policymakers must strengthen, not destabilize ESI.
- Jul 26, 2021Chamber Response to the European Commission Consultation on Digital Health Data and Services
The U.S. Chamber of Commerce welcomes the opportunity to provide the European Commission with comments on its digital health data and services – the European health data space survey.
- Jul 22, 2021The Path Forward: Unvaccinated Far More Likely to be Hospitalized as Delta Variant Spreads
This week’s Path Forward event featured a discussion about the safety of COVID vaccines and the spread of the Delta variant.
- Jul 14, 2021U.S. Chamber Letter on FY22 Labor and HHS Appropriations
This Hill letter was sent to the Members of the House Committee on Appropriations, on the Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies Appropriations legislation.
- Jun 25, 2021The Path Forward: WHO Expert Says Pandemic Is Not Over
This week’s Path Forward event featured Dr. Mike Ryan, executive director of the WHO, on why the pandemic is not over.
- May 05, 2021Global Task Force on Pandemic Response Launched by Leading Companies and Business Associations to Address Urgent COVID-19 Surges
The Global Task Force on Pandemic Response, a newly formed U.S.-based public-private partnership organized by the U.S. Chamber of Commerce and supported by Business Roundtable, announced today that it is working with the Chamber’s U.S.-India Business Council and the U.S.-India Strategic Partnership Forum to take three immediate actions to help address the COVID-19 surge in India.
- May 04, 2021U.S. Chamber Letter on H.R. 3, "Lower Drug Costs Now Act"
This Hill letter was sent to the Members of the U.S. House of Representatives, opposing H.R. 3, the "Lower Drug Costs Now Act." This bill is on the Legislative Leadership list for the “How They Voted” scorecard.
- Apr 30, 2021The Path Forward: Coronavirus Surge in India and School Reopening Successes in the US
This event focused on the American business community’s response to the devastating surge of coronavirus in India and school reopenings.
- Apr 29, 2021Expanding U.S.-Israel Partnerships in Health Innovation
Learn more about the U.S.-Israel Business Council's bilateral health innovation dialogue.